Drugmakers have asked the FDA for emergency authorization of molnupiravir, an antiviral pill that is used to treat mild to moderate COVID-19. Pharmaceutical companies Merck & Co. And Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the Food and Drug Administration for molnupiravir, an antiviral drug that offers the promise that COVID-19 could soon be treated by a pill. Molnupiravir is used to treat mild to moderate adult cases of COVID-19 that are at risk of worsening to severe COVID-19 or hospitalization, according to the companies. Source 1o.
molnupiravir is strange but it molnupiravir is interesting swiftly to understand molnupiravir correct what are the ins and outs of it.